{
  "docId": "019dd923-622c-750b-8b99-daa7bab7aec2",
  "docSlug": "f687a225f056",
  "documentTitle": "Enfusion, Inc. (ENFN)",
  "authorId": "54_Spruce_Point_Capital",
  "authorName": "Spruce Point Capital Management",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2024-03-14 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 4,
  "pageCount": 30,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "executive_summary",
  "function": "diagnose_problem",
  "density": "balanced",
  "nDataPoints": 6,
  "notes": "This is a classic activist short-seller research note slide.",
  "elementsJson": [
    "headline_text",
    "callout_box",
    "comparison_table"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b99-daa7bab7aec2/4",
  "deckHref": "/decks/019dd923-622c-750b-8b99-daa7bab7aec2",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b99-daa7bab7aec2.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b99-daa7bab7aec2#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.98,
        "x": 0.01,
        "y": 0.16
      },
      "kind": "callout",
      "text": "After conducting a forensic review of Enfusion, Inc. (NYSE: ENFN or “the Company”), Spruce Point believes that financial restatement risk is extremely high and investor expectations are likely to disappoint. The Company claims to be a high-growth SaaS provider of financial software with multi-year contracts but we don’t believe it to be a high quality one. We believe its product offering is under increased competitive pressures and that the CEO, CFO, CRO and CSO all having been replaced within the past two years is a telling sign. Multiple executives and Board members are connected to scandalous companies targeted both by short-sellers and the SEC. The CEO just enacted a large stock sale program ahead of the Investor Day. We see 40% - 60% downside risk.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fbe95c0f-ce76-4523-b194-7893b80f62be",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "We see 40% - 60% downside risk.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-78b5-7512-b5b5-ecd7d7f782ac",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "downside risk: 40% - 60%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd953-78b5-7512-b5b5-f0062aae9931",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.56,
        "w": 0.98,
        "x": 0.01,
        "y": 0.42
      },
      "kind": "table",
      "text": "Management & Board With Tainted History; Increasing Competitive Pressures Make Expectations Too High; Revenue At High Risk of Misstatement; 40% - 60% Downside Risk",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ed193a1e-a8ea-471e-a53a-82a9e4b237c5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.65,
        "x": 0.31,
        "y": 0.03
      },
      "kind": "title",
      "text": "Spruce Point Is Short Enfusion, Inc. (ENFN), Sees 40% - 60% Downside Risk",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "51e2f3e0-c698-4673-9db5-cac286b89216",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "c1a7193d-284e-43bf-a5a8-25076f6fb687",
      "evidence": "The slide is addressed to investors, indicating an effort to define and engage with the target audience.",
      "confidence": 0.7
    },
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "d975373e-76e6-424a-870e-e4f54fd8be6b",
      "evidence": "This slide serves as a brief overview of Spruce Point's stance on Enfusion, Inc., highlighting the main points of their argument.",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "ee116293-7ea6-48f7-8248-79216b33fa33",
      "evidence": "The slide explicitly details forensic review, accounting concerns, and governance issues typical of short-seller fraud exposure reports.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 4,
      "from": 1,
      "beatId": "1067a842-901b-4f08-95f3-4ec4c90b6b8c",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Ordinary World",
      "beatSlug": "heros-journey-ordinary-world",
      "evidence": "The document begins by establishing the context and background of Enfusion, Inc. (ENFN)",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Setup",
      "parentBeatSlug": "setup"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}